investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Risk Prediction for ER Negative Breast Cancer Recurrence
Melissa L Bondy
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Investigator from King's College London
Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets
Breast
Jian-Min Yuan
Cancer epidemiology cohorts in Shanghai and Singapore
Breast
Ana Maria Gonzalez-Angulo
Frequency and Outcome of BRCA1/2 Mutations in Jordanian Breast Cancer Women Treated at KHCC
Breast
Edgar G. Engleman
Applicability of Mouse Breast Cancer Models to Tumor-Immune Network Investigation
Breast
Global Noncommunicable Diseases Intiatives
Supply of equipment for the implementation of the National screening programme for colorectal, cervical and breast cancer (09SER01/05/22/01)
Breast
Maurizio Scaltriti
The Possible Role of the Novel Akt 3 R247C Mutation in Opposing to Anti-HER2 Ther
Breast
Georgios Giamas
Compound Screening for the Identification of LMTK3 Kinase-Inhibitors
Breast
Judy Lieberman
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer
Breast
Richard Peto
Large randomised trials and meta-analyses of breast cancer treatments
Breast